Family · Pharmaceutical analytical standards
Fenoldopam
A selective dopamine D1 receptor agonist, a benzazepine derivative, approved in the United States in 1997 for short-term intravenous use in hypertensive emergencies. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It mimics the effect of dopamine on D1 receptors and dilates most arterial beds, including the arteries of the kidneys, the gut and the heart.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
